Clinical Trial Results

Dry Needling in Multiple Sclerosis

NAINTERVENTIONAL Tampa, Florida

RECRUITING

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

PHASE3INTERVENTIONAL Loma Linda, California +4 more

RECRUITING

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Pheonix, Arizona +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

PHASE3INTERVENTIONAL Cullman, Alabama +4 more

RECRUITING

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING